Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,618 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Availability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarction.
Llevadot J, Giugliano RP, Antman EM, Wilcox RG, Gurfinkel EP, Henry T, McCabe CH, Charlesworth A, Thompson S, Nicolau JC, Tebbe U, Sadowski Z, Braunwald E; InTIME (Intravenous nPA for Treatment of Infarcting Myocardium Early) II Investigators. Llevadot J, et al. Among authors: braunwald e. Eur Heart J. 2001 Nov;22(22):2104-15. doi: 10.1053/euhj.2001.2622. Eur Heart J. 2001. PMID: 11686667 Clinical Trial.
Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial.
Antman EM, McCabe CH, Gurfinkel EP, Turpie AG, Bernink PJ, Salein D, Bayes De Luna A, Fox K, Lablanche JM, Radley D, Premmereur J, Braunwald E. Antman EM, et al. Among authors: braunwald e. Circulation. 1999 Oct 12;100(15):1593-601. doi: 10.1161/01.cir.100.15.1593. Circulation. 1999. PMID: 10517729 Clinical Trial.
First report of an intravenous and oral glycoprotein IIb/IIIa inhibitor (RPR 109891) in patients with recent acute coronary syndromes: results of the TIMI 15A and 15B trials.
Giugliano RP, McCabe CH, Sequeira RF, Frey MJ, Henry TD, Piana RN, Tamby JF, Jensen BK, Nicolas SB, Jennings LK, Wise RJ, Braunwald E. Giugliano RP, et al. Among authors: braunwald e. Am Heart J. 2000 Jul;140(1):81-93. doi: 10.1067/mhj.2000.107172. Am Heart J. 2000. PMID: 10874267 Clinical Trial.
TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy.
Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemos JA, Giugliano RP, McCabe CH, Braunwald E. Morrow DA, et al. Among authors: braunwald e. Circulation. 2000 Oct 24;102(17):2031-7. doi: 10.1161/01.cir.102.17.2031. Circulation. 2000. PMID: 11044416
Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14. The Thrombolysis in Myocardial Infarction (TIMI) 14 Investigators.
Antman EM, Gibson CM, de Lemos JA, Giugliano RP, McCabe CH, Coussement P, Menown I, Nienaber CA, Rehders TC, Frey MJ, Van der Wieken R, Andresen D, Scherer J, Anderson K, Van de Werf F, Braunwald E. Antman EM, et al. Among authors: braunwald e. Eur Heart J. 2000 Dec;21(23):1944-53. doi: 10.1053/euhj.2000.2243. Eur Heart J. 2000. PMID: 11071800 Clinical Trial.
Comparison of a 60- versus 90-minute determination of ST-segment resolution after thrombolytic therapy for acute myocardial infarction. In TIME-II Investigators. Intravenous nPA for Treatment of Infarcting Myocardium Early-II.
de Lemos JA, Antman EM, Giugliano RP, Morrow DA, McCabe CH, Cutler SS, Charlesworth A, Schröder R, Braunwald E. de Lemos JA, et al. Among authors: braunwald e. Am J Cardiol. 2000 Dec 1;86(11):1235-7, A5. doi: 10.1016/s0002-9149(00)01207-8. Am J Cardiol. 2000. PMID: 11090796 Clinical Trial.
1,618 results